arXiv:2610. 01278v1 Announce Type: new Abstract: Alzheimer's disease (AD) diagnosis requires sequential evidence acquisition under heterogeneous test costs and patient burden.
arXiv:2606. 19371v1 Announce Type: cross Abstract: Alzheimer's disease (AD) is a fatal disorder that destroys memory and cognitive skills in the elderly population.
arXiv:2606. 11794v1 Announce Type: cross Abstract: Neurodegenerative diseases such as Alzheimer's disease (AD) require accurate and scalable tools for assessing disease severity, yet current clinical staging remains time-intensive and prone to variability.
NeuronSifter is a framework for planning interventions in central nervous system microenvironments by converting treatment regimens into state‑conditional target‑occupancy fields and propagating them through microenvironment dynamics. It selects measurements based on their expected reduction in intervention loss, integrating typed outcomes into a unified posterior. In synthetic Alzheimer’s disease scenarios, occupancy conditioning improves trajectory probability scores and intervention ordering accuracy, and decision‑directed acquisition reduces terminal risk compared to a Bayesian experimental design planner.
arXiv:2608.28599v1 Announce Type: new Abstract: Clinical diagnosis is a step-by-step, cost-aware process: a physician orders examinations one at a time, observes the results, and updates the diagnosi...
arXiv:2607. 11656v1 Announce Type: cross Abstract: Accurate diagnostic classification and disease-severity prediction for Alzheimer's disease are hampered by the incompleteness and heterogeneity of real-world clinical data.
arXiv:2608.16831v2 Announce Type: replace Abstract: Pretrained large language models offer a practical foundation for learning useful behavior from few task-specific examples. We argue that current p...
arXiv:2605. 31014v2 Announce Type: replace Abstract: Multi-omics data provide complementary molecular characterizations of disease phenotypes and play an important role in disease diagnosis and subtype classification in precision medicine.
arXiv:2606. 24604v1 Announce Type: new Abstract: Longitudinal modelling of Alzheimer's disease progression is clinically useful only if it can describe not just the most likely next diagnosis, but how a patient may evolve over time and how reliable that forecast is.
Longitudinal modelling of Alzheimer's disease progression is clinically useful only if it can describe not just the most likely next diagnosis, but how a patient may evolve over time and how reliable that forecast is. Most deep learning approaches reduce this problem to single-step classification, treating cognitively normal, mild cognitive impairment, and dementia as flat categories while providing limited insight into how uncertainty accumulates across future visits.
Supervised fine-tuning with synthetic rationale data is widely assumed to improve language model performance on clinical prediction tasks by teaching models not just what to predict but why. We test this assumption on five-year Alzheimer's disease and related dementias (ADRD) prediction from longitudinal health histories.
arXiv:2606. 03995v1 Announce Type: cross Abstract: Background: Alzheimer's disease (AD) affects over 55 million people worldwide.
arXiv:2607. 17442v1 Announce Type: new Abstract: Background.